A blood test to detect multiple cancers and monitor leftover tumors after treatment
Part of Cancer, Digestive system, Hormones & metabolism, Lungs & breathing, Women’s health & pregnancy clinical trials.
This trial uses a blood test to find early signs of cancer or leftover tumor cells after treatment. It may help people with certain cancers or those with non-cancerous growths understand their condition better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older
- You have or had one of these cancers: ovarian, lung, pancreatic, colorectal, esophageal, breast, bladder, kidney, or stomach cancer
- You are getting or have gotten surgery or chemotherapy for your cancer
- You can safely donate blood
- If you don't have cancer, you must have a benign finding like a gallstone or polyp confirmed by imaging, or be having a routine health check-up
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new blood test can detect multiple types of cancer early by analyzing DNA fragments in your blood. Researchers are enrolling people recently diagnosed with cancer (before treatment starts) and people without cancer to develop and validate this detection method.
This observational study checks whether a blood test (a “cfDNA” test) can detect early signs of cancer or small amounts of cancer left after treatment. It may help doctors use a simple blood sample to improve cancer detection and follow-up.
This study is testing a blood-based test to detect unique molecules (called miRNAs) that may signal the presence of several types of gut or digestive system cancers. The goal is to develop a simple screening tool that could catch these cancers earlier.
This trial checks whether a blood test can detect early signs of multiple cancers in people who feel well. It may help find cancer earlier, when treatment is more likely to work.
This study collects blood from people with cancer and people without cancer (or with possible cancer) to test whether new blood tests can detect cancer earlier. Your blood samples help researchers evaluate how well these tests work.
This study is testing whether a blood test that looks for tiny bits of tumor DNA (ctDNA methylation) can help monitor how well treatment is working in people with colorectal cancer that has spread. If you are getting radiation and chemotherapy (with or without an immunotherapy drug), this trial may help your doctor see if the treatment is working sooner.
Hear when a new Lung Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.